SCHEMBL4723841

SCHEMBL4723841

CCCCN(C)c1ncco1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.36
AR P10275 1/20 0.35
LATS1 O95835 1/20 0.35
LATS2 Q9NRM7 1/20 0.35
FAAH O00519 2/20 0.34
CES1 P23141 1/20 0.34
MAPT P10636 1/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GPR84 Q9NQS5 2/20 0.32
PDE4B Q07343 2/20 0.32
PDE7A Q13946 2/20 0.32
PDE2A O00408 1/20 0.32
PDE5A O76074 1/20 0.32
PDE1B Q01064 1/20 0.32
PDE4D Q08499 1/20 0.32
PDE3A Q14432 1/20 0.32
PDE10A Q9Y233 1/20 0.32
UTS2R Q9UKP6 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4724154 0.89 HCAR3 (0.37) HRH3MAPTALDH1A1KDM4EPOLB
SCHEMBL4721464 0.83 ELANE (0.39) FAAHCES1MAPTUTS2R
SCHEMBL5111243 0.80 UTS2R (0.36) FAAHCES1MAPTALDH1A1KDM4E
SCHEMBL4721466 0.80 ELANE (0.38) FAAHCES1UTS2R
SCHEMBL4724016 0.75 HCAR3 (0.35) ARFAAHCES1MAPTPDE1B
SCHEMBL11527629 0.72 MLYCD (0.45) FAAHCES1ALDH1A1
SCHEMBL30088772 0.71 ALDH1A1 (0.43) FAAHCES1ALDH1A1
SCHEMBL4722845 0.71
SCHEMBL12889037 0.70 PTPN11 (0.40) ARLATS1LATS2MAPTALDH1A1
SCHEMBL4721756 0.70 GBA1 (0.35) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC. 2008-07-24 US disclosed
EP-1874780-A1 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2008-01-09 EP disclosed
WO-2006100591-A1 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors TBXA2R, P2RY4, PF4 HRH3 80/4885AR 2549/4885LATS1 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.